Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 942-639-6 | CAS number: -
PBT assessment
Administrative data
PBT assessment: overall result
- Name:
- Salicylaldehyde, oligomeric reaction with 1-chloro-2,3-epoxypropane and phenol
- Type of composition:
- legal entity composition of the substance
- Reference substance:
- Salicylaldehyde, oligomeric reaction with 1-chloro-2,3-epoxypropane and phenol
- Reference substance:
- Salicylaldehyde, oligomeric reaction with 1-chloro-2,3-epoxypropane and phenol
- Reference substance:
- Salicylaldehyde, oligomeric reaction with 1-chloro-2,3-epoxypropane and phenol
- Reference substance:
- Salicylaldehyde, oligomeric reaction with 1-chloro-2,3-epoxypropane and phenol
- Reference substance:
- Salicylaldehyde, oligomeric reaction with 1-chloro-2,3-epoxypropane and phenol
- Reference substance:
- Salicylaldehyde, oligomeric reaction with 1-chloro-2,3-epoxypropane and phenol
- PBT status:
- the substance is not PBT / vPvB
- Justification:
The substance was found not to be readily biodegradable and hydroylsis testing was not feasible on the basis of poor water solubility. In the absence of any data it must be assumed the substance may posseses P or vP properties however additional test data would be required to confirm. Experimentally derived Log Kow was found to be 4.07 therefore the substance was confirmed to be not Bioaccumulating.
The substance is also considered non toxic as there is no other data to suggest otherwise.There are no carcinogencity data available however based on results from the invivo comet assay there is no reason to suspect carcinogenic effects are likely.For mutagenic effects the comet assay was negative for effects in the glandular stomach and liver indictaing that the substance in unlikely to cause mutagenic activity in the absence or presence of metabolic activity. In the reproductive toxicity screening study no reproductive effects were seen and no development effects were seen in the absence of possible toxic effects seen in maternal animals. Also No toxicity was seen in the 28 day repeated dose oral toxicity study. Based on the following information the substance cannot be considered a PBT substance.
Reference
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
